ADHD Drug Problem
Attention deficit hyperactivity disorder, otherwise known as ADHS, has been known as a behavioral disorder for over a century. Recently, the disorder has become over-diagnosed. Typically, psychiatrists prescribe medication to help patients diagnosed with ADHD to function normally. The drugs are used to calm people down and increase concentration. In an attempt to fix the problem of over-prescription, drugs containing the active ingredients dextroamphetamine and methylphenidate are being strictly regulated by the Drug Enforcement Agency. Most of these drugs are stimulants, such as Ritalin, Adderall, Vyvance, and other generic brands. The limit on the manufacturing of prescription ADHD medication is a growing problem in the pharmaceutical field that must be addressed because the scarcity leaves prescriptions unfilled, increases prices, and hinders new prescriptions to be obtained.
A British doctor named Dr. Still first diagnosed ADHD in 1902. He named the disorder “Defect of Moral Control”, though he felt it was a medical issue rather than a spiritual problem. In 1922, ADHD became known as a behavioral disorder, rather than a spiritual concern. Prescription medications began to appear on the market in 1937, when Dr. Charles Bradley first used stimulates to treat hyperactive children. These medications, such as Ritalin, which was released in 1956, were used to treat only hyperactivity. In 1970, the current symptoms such as hyperactivity, lack of focus, and impulsiveness were added to the diagnosis. In 1980, the disorder got the name Attention Deficit Disorder. In 1987, the disease was broken into two categories: Attention Deficit Disorder and Attention Deficit Hyperactive Disorder. Adderall, one of the most common medications, was approved as sufficient treatment for both.
The quotas set by the Drug Enforcement Administration are too low to provide a sufficient amount of ADHD medication to fill the prescriptions that already exist. The...